EPTIS
BAM Logo

Parasite serology: Toxoplasma gondii

[Parazita szerológia: Toxoplasma gondii]

EPTIS factsheet 1278388 | Last revision 2024-10-21 | URL: https://www.eptis.bam.de/pts1278388 https://www.eptis.bam.de/pts1278388

PT provider
PT provider QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Based in Hungary
Language(s) English, Hungarian
Remarks Qualitative results are evaluated in the scheme.
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
2 samples of 1 mL lyophilised serum each Toxoplasmosis IgG Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis IgM Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis IgA Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis polyvalent Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis avidity Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasma gondii interpretation Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Aims of the PT scheme
Target group of participants In vitro medical laboratories
Linked to specific legislation / standards ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee on demand
Regularly operated Yes (four times a year)
Year of first operation
Contact details of the PT provider
Provider Contact person
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7
6720 Szeged
Hungary

Phone: +36 30 462 5864
Fax:
Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html
Ms. Eszter Mezey
Phone: +36 30 462 5864
Fax:
Email: mail@qualicont.com mail@qualicont.com
If you find any mistakes please contact the responsible EPTIS coordinator in Hungary, Ms Eszter Mezey. Ms Eszter Mezey.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5